Hide filtersShow filters × Close Bryan, Garnier & Co acts as Lead Manager and Sole Bookrunner on ASK’s EUR 22m IPO on Euronext Bryan, Garnier & Co acts as Co-manager of LDR 97m$ follow-on offering on NASDAQ. Bryan, Garnier & Co acts as Joint Manager and Bookrunner on Genomic Vision €26.4 m Euronext IPO, 4.7x oversubscribed IPO Scanship ASA Bryan, Garnier & Co acts as Lead Manager and Sole Bookrunner on Mcphy Energy’s € 32M Euronext IPO, 8.6x Oversubscribed. Bryan, Garnier & Co Acts as Joint Lead Manager and Joint Bookrunner of LDR Holding $86M IPO on NASDAQ Bryan, Garnier & Co announces the success of the IPO of Erytech with a Capital Increase of €28 Million Bryan, Garnier and Co advised Santen Pharmaceutical Co. Ltd. on its successful takeover of Novagali Pharma S.A. Bryan, Garnier & Co advises Cellectis on its acquisition of Cellartis and EUR 50 million capital increase Success of the initial public offering of Leadmedia Group with a total of €12.5 million raised Great success of Groupe Concoursmania’s IPO, offering 3.5x oversubscribed Success of the initial public offering of Zealand Pharma
